Cargando…

Conditions Where Internal Drugs Are Indicated

Detalles Bibliográficos
Autor principal:	Buckley, J. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1904
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074964/ https://www.ncbi.nlm.nih.gov/pubmed/30750297

Ejemplares similares

Cases Where the Use of Oxpara Is Indicated
por: Hazell, E. F.
Publicado: (1904)

Hip arthroscopy and osteoarthritis: Where are the limits and indications?
por: Mella, Claudio, et al.
Publicado: (2015)

Where the Backboned Animals Begin
por: Buckley, Arabella B.
Publicado: (1883)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
por: Mesnier, Jules, et al.
Publicado: (2022)

Where are we now? Expanding AAHKS internationally
por: Sierra, Rafael J.
Publicado: (2018)

Innovation indices: the need for positioning them where they properly belong
por: Kozłowski, Jan
Publicado: (2015)

Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022)

Enlarged and uncommon indications for ALPPS—where do we stand?
por: Truant, Stéphanie
Publicado: (2022)

Where are the paediatricians? An international survey to understand the global paediatric workforce
por: Harper, Beth D, et al.
Publicado: (2019)

Post-COVID-19 Condition: Where Are We Now?
por: Boaventura, Paula, et al.
Publicado: (2022)

Quality management: where is the evidence? Developing an indicator-based approach in Kenya
por: Prytherch, Helen, et al.
Publicado: (2017)

50% adherence of patients suffering chronic conditions – where is the evidence?
por: Mathes, Tim, et al.
Publicado: (2012)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Drug misuse in India: Where do we stand & where to go from here?
por: Avasthi, Ajit, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2022)

Why do anti-inflammatory signals of bone marrow-derived stromal cells improve neurodegenerative conditions where anti-inflammatory drugs fail?
por: de Munter, J. P. J. M., et al.
Publicado: (2020)

Application of Vaughan's Mode of Delivery, Where Forceps Were Definitely Indicated
por: Keith-Thompson, Mary
Publicado: (1939)

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
por: Harari, Sergio, et al.
Publicado: (2015)

New drug discovery: Where are we heading to?
por: Yadav, M. R.
Publicado: (2013)

Magnetic Drug Delivery: Where the Field Is Going
por: Price, Paige M., et al.
Publicado: (2018)

Drug Design: Where We Are and Future Prospects
por: Zagotto, Giuseppe, et al.
Publicado: (2021)

Where are the drugs? The scarcity of medications in the Western Pacific
por: The Lancet Regional Health – Western Pacific
Publicado: (2023)

Where do you want your drugs delivered?
por: Ding, Ming, et al.
Publicado: (2020)

Systemic psychotherapy with families where someone has an autism spectrum condition
por: Helps, Sarah
Publicado: (2016)

International workshop on “professionalism in the practice of medicine- where are we now?”
por: Paltiel, Ora, et al.
Publicado: (2017)

Face Transplant: Indications, Outcomes, and Ethical Issues—Where Do We Stand?
por: La Padula, Simone, et al.
Publicado: (2022)

Where is the evidence for emergency planning: a scoping review
por: Challen, Kirsty, et al.
Publicado: (2012)

Where does the money go to? Cost analysis of gynecological patients with a benign condition
por: Pynnä, Kristiina, et al.
Publicado: (2021)

Where Did Life Begin? Testing Ideas in Prebiotic Analogue Conditions
por: Deamer, David
Publicado: (2021)

The ‘What, Why, Where and How’ of Delivering a Drug
por: Mukherjee, Kusumika
Publicado: (2020)

Drug Research Meets Network Science: Where Are We?
por: Recanatini, Maurizio, et al.
Publicado: (2020)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
por: do Carmo Silva, Lívia, et al.
Publicado: (2020)

Tumor Models and Drug Targeting In Vitro—Where Are We Today? Where Do We Go from Here?
por: Krüger, Marcus, et al.
Publicado: (2023)

Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
por: Alamri, Ayedh K., et al.
Publicado: (2023)

COVID-19 Outbreak in International Airport – Where the Incidence Case Occurs?
por: Sriwijitalai, Won, et al.
Publicado: (2020)

Celebrating International Women’s Day: where does this leave the paramedic profession?
por: Wilson, Caitlin, et al.
Publicado: (2022)

4th International Conference: Where Cosmology and Fundamental Physics Meet
Publicado: (2003)

Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?
por: Palrasu, Manikandan, et al.
Publicado: (2022)

Intensive Care Medicine: Where We Are and Where We Want To Go?
por: Moreno, R. P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5tj3p0rv9sjig9mltsqg200a7m